Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amla for Metabolic Syndrome
NCT03633630Phase 3Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Apr 2019
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Waist Circumference at 90 days, Triglycerides at 90 days and 4 more. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT03633630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633630.